Pricing Log in Create free account

Co-Diagnostics, Inc. (CODX) vs Nexalin Technology, Inc. (NXL)

Co-Diagnostics, Inc. and Nexalin Technology, Inc. are both Medical Devices companies. Co-Diagnostics, Inc. is the larger, with a market value of $2.4M against $1.7M — 1.4× the size. Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against −28.1%. Nexalin Technology, Inc. has the higher net margin (−4,138.5% vs −6,522.9%) and the lower return on invested capital (−1,108.8% vs −337.7%). Across the 17 metrics below, Nexalin Technology, Inc. leads on 9 and Co-Diagnostics, Inc. on 8.

Valuation

Metric CODX NXL Medical Devices median
P/E n/m n/m 24.94
P/S 1.55 4.77 2.66
P/B 0.09 0.68 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA 0.05 n/m 11.42
EV/Sales (3.51) 0.16 2.76
Earnings yield (9,218.38%) (980.57%) (12.66%)
Free cash flow yield (2,451.41%) (612.33%) (7.18%)

Profitability

Metric CODX NXL Medical Devices median
Gross margin 43.47% 86.14% 57.76%
Operating margin (6,787.47%) (4,201.66%) (14.84%)
Net margin (6,522.91%) (4,138.49%) (14.45%)
Free cash flow margin (3,807.94%) (2,917.96%) (5.70%)
Return on equity (174.77%) (240.25%) (10.56%)
Return on assets (149.25%) (187.89%) (17.26%)
Return on invested capital (337.68%) (1,108.82%) (5.22%)

Growth

Metric CODX NXL Medical Devices median
Revenue growth (TTM) (28.12%) 24.26% 10.41%
EPS growth (last fiscal year) 5.34% 39.76% 28.17%
Revenue growth, 5-year CAGR (61.60%) 4.42% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CODX NXL Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 1.81 1.25 2.67
Net debt to EBITDA 0.24 0.44 0.54

Dividend

Metric CODX NXL Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric CODX NXL Medical Devices median
Market cap 2.44m 1.69m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack